Nexplanon 68 MG implants
Ended Awarded Last action
- Contract number
- SPE2DR26FCFL2
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,311
Award facts
- Contract value 100% obligated
- $21,311.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $21,311.10 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Nexplanon 68 mg implants, a subdermal contraceptive device. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation, demonstrating the company's competitive capability in unrestricted federal procurement. The delivery order is scheduled for completion by December 19, 2025, with performance taking place at the awardee's Park Ridge location.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, awarded on November 13, 2025, with a $499.999 billion ceiling value extending through December 31, 2036. The PPV-G GEN V program represents a $30.3 billion acquisition strategy designed to provide comprehensive pharmaceutical and medical supply support to Department of Defense healthcare facilities worldwide. As a regional prime vendor contractor under this program, DMS Pharmaceutical Group is authorized to supply branded and generic prescription drugs, biologics, and medical consumables to support recurring military medical supply requirements across the global DoD healthcare system.
Quick answers
Who was awarded contract SPE2DR26FCFL2?
SPE2DR26FCFL2 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 28, 2025.
How much is contract SPE2DR26FCFL2 worth?
The government has obligated $21,311 on SPE2DR26FCFL2.
Is contract SPE2DR26FCFL2 an order under another contract?
Yes. SPE2DR26FCFL2 is a delivery order under SPE2DR25D9133, an indefinite delivery contract.
Was contract SPE2DR26FCFL2 competed?
The extent of competition for SPE2DR26FCFL2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award